Suppression of the hydrazine-induced formation of megamitochondria in the rat liver by coenzyme Q10. 1995

K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
Department of Cell Biology and Molecular Pathology, Nagoya University School of Medicine, Japan.

The effects of coenzyme Q10 (CoQ10) on the hydrazine-induced changes in the structure of mitochondria and those in antioxidant systems of the liver were investigated using rats as experimental animals. Animals were placed on a powdered diet containing 1.0% hydrazine for 7-8 days in the presence or absence of the combined treatment with CoQ10. Results obtained were as follows: (a) treatment of animals with CoQ10 prevented the hydrazine-induced formation of megamitochondria in the liver; (b) changes observed in the liver of the hydrazine-treated animals in comparison to the control were increases in the contents of alpha-tocopherol and CoQ analogs, increases in the levels of lipid peroxidation, decreases in the level of reduced glutathione with increases in that of oxidized glutathione, and increases in the ratio of unsaturated to saturated fatty acids in phospholipid domains of mitochondrial membranes; and (c) administration of CoQ10 to hydrazine-treated animals suppressed enhanced lipid peroxidation and improved lowered adenosine diphosphate/O ratios of mitochondria. The present data suggest that CoQ10 suppresses the hydrazine-induced formation of megamitochondria by scavenging free radicals generated from hydrazine and its metabolites.

UI MeSH Term Description Entries
D008297 Male Males
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D003067 Coenzymes Small molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes. Coenzyme,Enzyme Cofactor,Cofactors, Enzyme,Enzyme Cofactors,Cofactor, Enzyme
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014451 Ubiquinone A lipid-soluble benzoquinone which is involved in ELECTRON TRANSPORT in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals. Coenzyme Q
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
June 1994, Experimental and molecular pathology,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
January 2006, Asian Pacific journal of cancer prevention : APJCP,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
October 1983, Experimental and molecular pathology,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
January 1997, Free radical biology & medicine,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
February 1987, Toxicology and applied pharmacology,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
July 1996, Toxicology letters,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
January 1975, Acta pathologica japonica,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
March 1975, Acta pathologica japonica,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
October 1980, Nihon Gan Chiryo Gakkai shi,
K Adachi, and T Matsuhashi, and Y Nishizawa, and J Usukura, and J Popinigis, and T Wakabayashi
January 1975, Acta pathologica japonica,
Copied contents to your clipboard!